Insertable cardiac monitors are becoming a widely used diagnostic tool to detect arrhythmias. The Confirm Rx™ ICM has been updated with SharpSense™ technology to further improve the performance of the device. This compendium is a collection of product and clinical data to help you make informed decisions for your patients.
First study to evaluate performance of the Confirm Rx ICM predecessor DM2102 ICM to detect AF published in the Journal of Cardiovascular Electrophysiology in September 2016:
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?